Table 1 Patients’ demographic data and disease characteristics
From: Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn’s disease
Number | Percent | ||
|---|---|---|---|
Male/female | 30/26 | 53.6/46.4 | |
Age at diagnosis (years) | 26 ± 11 | ||
Disease duration (years) | 6 ± 5 | ||
Clinical remission | 52 | 92.3 | |
Smoking status | current | 11 | 19.6 |
never smoked | 36 | 64.3 | |
past smoking | 9 | 16.1 | |
Previous surgery | 9 | 16.1 | |
Perianal disease | 13 | 23.2 | |
Current medical treatment | Thiopurine | 25 | 44.6 |
Anti-TNF | 21 | 37.5 | |
Combined anti-TNF + thiopurine | 7 | 12.5 | |
No medical treatment | 11 | 19.6 | |